Found: 60
Select item for more details and to access through your institution.
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.
- Published in:
- Genes, Chromosomes & Cancer, 2016, v. 55, n. 4, p. 375, doi. 10.1002/gcc.22341
- By:
- Publication type:
- Article
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 12, p. 818, doi. 10.1002/gcc.22293
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1845, doi. 10.1002/ajh.27421
- By:
- Publication type:
- Article
Continuous venetoclax in treatment‐naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. E237, doi. 10.1002/ajh.27009
- By:
- Publication type:
- Article
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. E176, doi. 10.1002/ajh.26502
- By:
- Publication type:
- Article
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E95, doi. 10.1002/ajh.26437
- By:
- Publication type:
- Article
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 480, doi. 10.1002/ajh.23668
- By:
- Publication type:
- Article
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia.
- Published in:
- BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/715391
- By:
- Publication type:
- Article
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.
- Published in:
- Cytometry. Part B, 2018, v. 94, n. 1, p. 121, doi. 10.1002/cyto.b.21595
- By:
- Publication type:
- Article
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 2, p. 766, doi. 10.3390/ijms25020766
- By:
- Publication type:
- Article
An unusual case of untreated chronic lymphocytic leukemia patient presenting with Rhodococcus equi bacteriemia.
- Published in:
- American Journal of Hematology, 1996, v. 52, n. 2, p. 126, doi. 10.1002/(SICI)1096-8652(199606)52:2<126::AID-AJH16>3.0.CO;2-F
- By:
- Publication type:
- Article
A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results.
- Published in:
- Genes, 2020, v. 11, n. 12, p. 1453, doi. 10.3390/genes11121453
- By:
- Publication type:
- Article
AML-347: A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-Center Study of FLT3-Mutated AML Patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitor Administration in Real-Life Clinical Practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S307, doi. 10.1016/S2152-2650(21)01729-8
- By:
- Publication type:
- Article
Poster: AML-347: A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-Center Study of FLT3-Mutated AML Patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitor Administration in Real-Life Clinical Practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S210, doi. 10.1016/S2152-2650(21)01316-1
- By:
- Publication type:
- Article
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors.
- Published in:
- Current Oncology, 2021, v. 28, n. 4, p. 2439, doi. 10.3390/curroncol28040223
- By:
- Publication type:
- Article
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00865-z
- By:
- Publication type:
- Article
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
- Published in:
- British Journal of Haematology, 2008, v. 142, n. 4, p. 529, doi. 10.1111/j.1365-2141.2008.07227.x
- By:
- Publication type:
- Article
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34<sup>+</sup> cells.
- Published in:
- British Journal of Haematology, 2004, v. 126, n. 4, p. 501, doi. 10.1111/j.1365-2141.2004.05086.x
- By:
- Publication type:
- Article
Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients.
- Published in:
- British Journal of Haematology, 2003, v. 120, n. 6, p. 953, doi. 10.1046/j.1365-2141.2003.04176.x
- By:
- Publication type:
- Article
rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors' response by fluorescence in situ hybridization on May–Grunwald–Giemsa-stained bone marrow samples.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 3, p. 652, doi. 10.1046/j.1365-2141.2002.03867.x
- By:
- Publication type:
- Article
Dendritic cells in acute promyelocytic leukaemia.
- Published in:
- British Journal of Haematology, 2001, v. 114, n. 4, p. 830, doi. 10.1046/j.1365-2141.2001.03023.x
- By:
- Publication type:
- Article
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real‐world setting. A GIMEMA‐ERIC and US study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 22, p. 8468, doi. 10.1002/cam4.3470
- By:
- Publication type:
- Article
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 3, p. 555, doi. 10.1002/cam4.226
- By:
- Publication type:
- Article
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 11, p. 987, doi. 10.3390/diagnostics10110987
- By:
- Publication type:
- Article
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1033413
- By:
- Publication type:
- Article
Primary Skull Base Lymphoma with Concomitant Petrous Cholesteatoma: Case Report.
- Published in:
- Journal of International Advanced Otology, 2010, v. 6, n. 1, p. 112
- By:
- Publication type:
- Article
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 5, p. 374, doi. 10.1111/j.1600-0609.2007.00831.x
- By:
- Publication type:
- Article
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 5, p. 365, doi. 10.1111/j.1600-0609.2007.00839.x
- By:
- Publication type:
- Article
A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin.
- Published in:
- European Journal of Haematology, 2005, v. 75, n. 6, p. 515, doi. 10.1111/j.1600-0609.2005.00558.x
- By:
- Publication type:
- Article
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: correlations with aetiological and clinical–biological findings.
- Published in:
- European Journal of Haematology, 2004, v. 73, n. 5, p. 351, doi. 10.1111/j.1600-0609.2004.00305.x
- By:
- Publication type:
- Article
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics.
- Published in:
- European Journal of Haematology, 2004, v. 72, n. 1, p. 18, doi. 10.1046/j.0902-4441.2004.00172.x
- By:
- Publication type:
- Article
Differentiation of follicular dendritic sarcoma cells into functional myeloid-dendritic cell-like elements.
- Published in:
- European Journal of Haematology, 2003, v. 70, n. 5, p. 315, doi. 10.1034/j.1600-0609.2003.00042.x
- By:
- Publication type:
- Article
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low‐risk chronic lymphocytic leukaemia patients.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 5, p. 953, doi. 10.1111/bjh.18946
- By:
- Publication type:
- Article
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1068, doi. 10.1111/bjh.16865
- By:
- Publication type:
- Article
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 2, p. 229, doi. 10.1111/bjh.15174
- By:
- Publication type:
- Article
Dendritic Cells and Vascular Endothelial Growth Factor in Colorectal Cancer: Correlations with Clinicobiological Findings.
- Published in:
- Oncology, 2005, v. 68, n. 2/3, p. 276, doi. 10.1159/000086784
- By:
- Publication type:
- Article
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death.
- Published in:
- Scientific Reports, 2016, p. 26280, doi. 10.1038/srep26280
- By:
- Publication type:
- Article
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile.
- Published in:
- European Heart Journal, 2005, v. 26, n. 18, p. 1838, doi. 10.1093/eurheartj/ehi289
- By:
- Publication type:
- Article
Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 7, p. 1002, doi. 10.1002/cncr.28522
- By:
- Publication type:
- Article
Circulating Endothelial Cells in Patients With Chronic Lymphocytic Leukemia.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 8, p. 1926, doi. 10.1002/cncr.24961
- By:
- Publication type:
- Article
Delirium in acute promyelocytic leukemia patients: two case reports.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in Splenic Marginal Zone Lymphoma.
- Published in:
- Journal of Biomedicine & Biotechnology, 2011, p. 1, doi. 10.1155/2011/691493
- By:
- Publication type:
- Article
Chronic Lymphocytic Leukemia: Prognostic Factors in the Era of Novel Drugs.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2732, doi. 10.3390/cancers16152732
- By:
- Publication type:
- Article
First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3859, doi. 10.3390/cancers15153859
- By:
- Publication type:
- Article
TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype.
- Published in:
- Cancers, 2022, v. 14, n. 15, p. 3715, doi. 10.3390/cancers14153715
- By:
- Publication type:
- Article
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3240, doi. 10.3390/cancers13133240
- By:
- Publication type:
- Article
Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemia.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 567, doi. 10.1002/hon.3080
- By:
- Publication type:
- Article
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID‐19 pandemic and at the start of the vaccination program. A Campus CLL report.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 570, doi. 10.1002/hon.2899
- By:
- Publication type:
- Article